The Chemours Company CC
Set alert
13.16 USD 0.00 0.00%
At close
13.74 +0.58 +4.41%
Pre-market · Nov 3, 8:58 AM ET
Day range unavailable
10.44 52-week range 28.67
- YTD
- +11.62%
- 1 year
- +3.79%
- Open
- —
- Prev close
- 13.16
- Mkt cap
- 1.98B
- Vol
- 0
- Avg vol
- 2.32M
- EPS
- -2.02
- P/E
- 0.00
- Div yield
- 2.65%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 7.08
- Beta
- 1.47
- Short ratio
- 7.07
- Inst. own
- 91.34%
- Dividend
- 0.35
- Ex-div date
- Nov 15, 2026
- Earnings
- Feb 18, 2027
- 50-d avg
- 14.23
- 200-d avg
- 18.40
- 1y target
- 16.50
Analyst view
Consensus: hold
Hold
Price target (mean) 16.50 +25.4% upside
Now 13.16
- Target (low)
- 14.00
- Target (mean)
- 16.50
- Target (high)
- 20.00
Ratings (0m) 10 2 buy · 8 hold · 0 sell
- Strong buy0
- Buy2
- Hold8
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 9
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.25771 | 0.17 – 0.38566 | 0.20 | +28.8% | 1.53B | +2.5% | 9 |
| Next quarter | 0.18211 | 0.09 – 0.33 | 0.05 | +264.2% | 1.42B | +6.5% | 9 |
| Current year | 0.9481 | 0.76 – 1.20 | 0.95 | -0.2% | 5.91B | +1.8% | 10 |
| Next year | 1.86 | 1.62 – 2.13 | 0.9481 | +96.0% | 6.20B | +4.8% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 14, 2026 | Mizuho | Downgrade | Outperform | Neutral |
| Oct 13, 2026 | Barclays | Initiated | — | Equal-Weight |
| Oct 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Sep 30, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 13, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 13, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Aug 10, 2026 | UBS | Downgrade | Buy | Neutral |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 1, 2026 | Mizuho | Maintained | Outperform | Outperform |
| May 21, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| May 11, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 11, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 8, 2026 | UBS | Maintained | Buy | Buy |
| Apr 28, 2026 | Truist Securities | Maintained | Buy | Buy |
| Apr 9, 2026 | UBS | Maintained | Buy | Buy |
| Apr 9, 2026 | Truist Securities | Maintained | Buy | Buy |
| Mar 5, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Feb 25, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Feb 23, 2026 | UBS | Maintained | Buy | Buy |
| Feb 23, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 23, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 23, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jan 21, 2026 | Truist Securities | Maintained | Buy | Buy |
| Dec 3, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Nov 11, 2025 | UBS | Maintained | Buy | Buy |
| Nov 10, 2025 | Truist Securities | Maintained | Buy | Buy |
| Nov 10, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 16, 2025 | Mizuho | Maintained | Outperform | Outperform |